Journal of Pharmaceutical Policy and Practice

Clinical Pharmacy Practice and Policy Research in High-Income Economies: Evidence, Impact, Implementation, and the Way Forward

In high-income economies, pharmacy practice plays a pivotal role in optimizing medication use and improving patient outcomes. Pharmacists routinely conduct comprehensive medication reviews, manage chronic diseases, and provide specialized care in both community and hospital settings. As integral members of multidisciplinary healthcare teams, pharmacists are increasingly recognized for their expertise, with strong emphasis placed on advanced education, training, specialization, and the expansion of professional roles. Several high-income countries are also moving towards pharmacist prescribing, further broadening their scope of practice. Numerous high-quality studies employing diverse research methodologies have demonstrated the value of pharmacist-led interventions. Key challenges for pharmacy practice in high-income economies include addressing healthcare disparities, managing high-cost and specialized medicines, and using artificial intelligence to improve patient outcomes.

This article collection seeks to address the broad range of issues shaping access to medicines, their use, and clinical pharmacy practice. We invite research articles, reviews, and commentaries on topics including, but not limited to:

• Evidence and impact of clinical pharmacy practice research
• Evolving health systems and community pharmacy practice
• Access to medicines, medicine pricing, high-cost medicines, biosimilars
• Healthcare workforce
• Expanded roles for pharmacists and specialized care
• Implementation research
• Innovation in the pharmaceutical industry
• Clinical pharmacy practice models
• Artificial intelligence, technology, and pharmacy practice
• Pharmacogenomics and precision medicine
• Deprescribing
• Methodological approaches in clinical pharmacy practice studies
• Randomized controlled trials in pharmacy practice research
• Medicine shortages
• Economic evaluation of pharmacy services

Submissions on other relevant topics within the broader field are also welcome.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer review if they can pass the desk assessments as part of our standard editorial process; the Guest Advisor for this Collection will not be handling the manuscripts (unless they are an Editorial Board member).

The series is currently open for submissions and will run until 31 December 2029.

Please contact Catherine Teng at [email protected]  with any queries and discount codes regarding this Article Collection.